RHOA inactivation enhances Wnt signalling and promotes colorectal cancer

Nature Communications

Volumn 5, Issue , 2014, Pages

  Rodrigues, Paulo ^a,b   Macaya, Irati ^a,b   Bazzocco, Sarah ^a,b   Mazzolini, Rocco ^a,b   Andretta, Elena ^a,b   Dopeso, Higinio ^a,b   Mateo Lozano, Silvia ^a,b   Bilić, Josipa ^a,b   Cartón García, Fernando ^a,b   Nieto, Rocio ^a,b   Suárez López, Lucia ^a,b   Afonso, Elsa ^a,b   Landolfi, Stefania ^c   Hernandez Losa, Javier ^c   Kobayashi, Kazuto ^d   Cajal, Santiago Ramón Y ^c   Tabernero, Josep ^c   Tebbutt, Niall C ^e   Mariadason, John M ^e   Schwartz, Simo ^a,b   Arango, Diego ^a,b   more..

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; WNT PROTEIN; RHOA PROTEIN, HUMAN;

APOPTOSIS; CANCER; GENETIC DIFFERENTIATION; GERM CELL; MEMBRANE; SIGNALING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR INVASION; TUMOR XENOGRAFT; WNT SIGNALING PATHWAY; ANIMAL; COLON TUMOR; DISEASE COURSE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

MURINAE; MUS;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MICE; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84923266167     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6458     Document Type: Article

References (70)

1. Chang, E. H., Gonda, M. A., Ellis, R. W., Scolnick, E. M. & Lowy, D. R. Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses. Proc. Natl Acad. Sci. USA 79, 4848-4852 (1982).
2. Defeo, D. et al. Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. Biochemistry 78, 3328-3332 (1981).
3. Etienne-Manneville, S. & Hall, A. Rho GTPases in cell biology. Nature 420, 629-635 (2002).
4. Bishop, a. L. & Hall, a. Rho GTPases and their effector proteins. Biochem. J. 348(Pt 2): 241-255 (2000).
5. Olson, M. F., Ashworth, A. & Hall, A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269, 1270-1272 (1995).
6. Van Aelst, L. & D'Souza-Schorey, C. Rho GTPases and signaling networks. Genes Dev. 11, 2295-2322 (1997).
7. Hall, A. Rho GTPases and the actin cytoskeleton. Science 279, 509-514 (1998).
8. Sahai, E. & Marshall, C. J. RHO-GTPases and cancer. Nat. Rev. Cancer 2, 133-142 (2002).
9. Malliri, A. & Collard, J. G. Role of Rho-family proteins in cell adhesion and cancer. Curr. Opin. Cell Biol. 15, 583-589 (2003).
10. Qiu, R. G., Chen, J., McCormick, F. & Symons, M. A role for Rho in Ras transformation. Proc. Natl Acad. Sci. USA 92, 11781-11785 (1995).
11. Leve, F. & Morgado-Díaz, J. a. Rho GTPase signaling in the development of colorectal cancer. J. Cell Biochem. 113, 2549-2559 (2012).
12. Itoh, K. et al. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat. Med. 5, 221-225 (1999).
13. Faried, a. et al. Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma. Eur. J. Surg. Oncol. 31, 410-414 (2005).
14. Kamai, T. et al. RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer. BJU Int. 91, 234-238 (2003).
15. Sahai, E. & Marshall, C. J. ROCK and Dia have opposing effects on adherens junctions downstream of Rho. Nat. Cell Biol. 4, 408-415 (2002).
16. Malvezzi, M., Bertuccio, P., Levi, F., La Vecchia, C. & Negri, E. European cancer mortality predictions for the year 2012. Ann. Oncol. 23, 1044-1052 (2012).
17. Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843-850 (2005).
18. Clevers, H. Wnt/beta-catenin signaling in development and disease. Cell 127, 469-480 (2006).
19. Network, T. C. G. A. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
20. Schlessinger, K., Hall, A. & Tolwinski, N. Wnt signaling pathways meet Rho GTPases. Genes Dev. 23, 265-277 (2009).
21. Bakker, E. R. M. et al. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice. Carcinogenesis 34, 2629-2638 (2013).
22. Yang, M. et al. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway. Proc. Natl Acad. Sci. USA 102, 6027-6032 (2005).
23. Rusovici, R., Ghaleb, A., Shim, H., Yang, V. W. & Yun, C. C. Lysophosphatidic acid prevents apoptosis of Caco-2 colon cancer cells via activation of mitogen-activated protein kinase and phosphorylation of Bad. Biochim. Biophys. Acta 1770, 1194-1203 (2007).
24. Tatsuta, M. et al. Induction by lysophosphatidic acid of peritoneal and pleural metastases of intestinal cancers induced by azoxymethane in Wistar rats. Cancer Lett. 219, 137-145 (2005).
25. Contos, J. J. A., Ishii, I. & Chun, J. Lysophosphatidic acid receptors. Mol. Pharmacol. 58, 1188-1196 (2000).
26. Fritz, G., Just, I. & Kaina, B. Rho GTPases are over-expressed in human tumors. Int. J. Cancer 81, 682-687 (1999).
27. Wang, H. et al. Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo. J. Exp. Clin. Cancer Res. 29, 123 (2010).
28. Arango, D. et al. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology 129, 874-884 (2005).
29. Bellovin, D. I., Bates, R. C., Muzikansky, A., Rimm, D. L. & Mercurio, A. M. Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease. Cancer Res. 65, 10938-10945 (2005).
30. Bellovin, D. I. et al. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 25, 6959-6967 (2006).
31. Kobayashi, K. et al. Survival of developing motor neurons mediated by Rho GTPase signaling pathway through Rho-kinase. J. Neurosci. 24, 3480-3488 (2004).
32. Sanno, H. et al. Control of postnatal apoptosis in the neocortex by RhoAsubfamily GTPases determines neuronal density. J. Neurosci. 30, 4221-4231 (2010).
33. Dopeso, H. et al. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis. Cancer Res. 69, 7430-7438 (2009).
34. Mazzolini, R. et al. Brush border myosin Ia has tumor suppressor activity in the intestine. Proc. Natl Acad. Sci. USA 109, 1530-1535 (2012).
35. Nusrat, A. et al. Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. Proc. Natl Acad. Sci. USA 92, 10629-10633 (1995).
36. Wang, H.-R. et al. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 302, 1775-1779 (2003).
37. Baas, A. F. et al. Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 116, 457-466 (2004).
38. Braga, V. M., Machesky, L. M., Hall, a. & Hotchin, N. a. The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J. Cell Biol. 137, 1421-1431 (1997).
39. Nelson, W. J. & Nusse, R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303, 1483-1487 (2004).
40. Van de Wetering, M. et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241-250 (2002).
41. Van de Wetering, M. et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 4, 609-615 (2003).
42. Zhu, Y. et al. Dvl2-dependent activation of Daam1 and RhoA regulates Wnt5a-induced breast cancer cell migration. PLoS ONE 7, e37823 (2012).
43. Huang, S.-M. A. et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461, 614-620 (2009).
44. Lee, J. H. et al. Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 447, 1017-1020 (2007).
45. Clevers, H. & Nusse, R. Wnt/β-catenin signaling and disease. Cell 149, 1192-1205 (2012).
46. Simons, M. & Mlodzik, M. Planar cell polarity signaling: from fly development to human disease. Annu. Rev. Genet. 42, 517-540 (2008).
47. Pope, J. L. et al. Claudin-1 overexpression in intestinal epithelial cells enhances susceptibility to adenamatous polyposis coli-mediated colon tumorigenesis. Mol. Cancer 13, 167 (2014).
48. Luo, F., Poulogiannis, G., Ye, H., Hamoudi, R. & Arends, M. J. Synergism between K-rasVal12 and mutant Apc accelerates murine large intestinal tumourigenesis. Oncol. Rep. 26, 125-133 (2011).
49. Larriba, M. J. et al. Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer. PLoS ONE 6, e23524 (2011).
50. Weber, J. D. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27KIP1. J. Biol. Chem. 272, 32966-32971 (1997).
51. Nakamura, S. Geranylgeranylated Rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated Rat FRTL-5 Cells. J. Biol. Chem. 272, 13-16 (1997).
52. Olson, M. F., Paterson, H. F. & Marshall, C. J. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394, 295-299 (1998).
53. Sansom, O. J. et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 18, 1385-1390 (2004).
54. Ohata, H. et al. Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells. Cancer Res. 72, 5101-5110 (2012).
55. Vaezi, A., Bauer, C., Vasioukhin, V. & Fuchs, E. Actin cable dynamics and Rho/ Rock orchestrate a polarized cytoskeletal architecture in the early steps of assembling a stratified epithelium. Dev. Cell 3, 367-381 (2002).
56. Ozdamar, B. et al. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307, 1603-1609 (2005).
57. Ordóñez-Morán, P. et al. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J. Cell Biol. 183, 697-710 (2008).
58. Mariadason, J. M. et al. Down-regulation of β-catenin TCF signaling is linked to colonic epithelial cell differentiation. Cancer Res. 61, 3465-3471 (2001).
59. Schwitalla, S. et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152, 25-38 (2013).
60. Ridley, A. J. Life at the leading edge. Cell 145, 1012-1022 (2011).
61. Melendez, J. et al. Cdc42 coordinates proliferation, polarity, migration, and differentiation of small intestinal epithelial cells in mice. Gastroenterology 145, 808-819 (2013).
62. Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563-572 (2002).
63. Lee, J. J. & Lotze, M. T. Molecular basis of metastasis. N. Engl. J. Med. 360, 1679 author reply 1679-1680 (2009).
64. Valastyan, S. et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032-1046 (2009).
65. Chan, C.-H. et al. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat. Cell Biol. 12, 457-467 (2010).
66. Horiuchi, A. et al. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab. Invest. 83, 861-870 (2003).
67. Mardilovich, K., Olson, M. F. & Baugh, M. Targeting Rho GTPase signaling for cancer therapy. Future Oncol. 8, 165-177 (2012).
68. Rath, N. & Olson, M. F. Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy. EMBO Rep. 13, 900-908 (2012).
69. Madison, B. B. et al. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J. Biol. Chem. 277, 33275-33283 (2002).
70. De Jonge, H. J. M. et al. Evidence based selection of housekeeping genes. PLoS ONE 2, e898 (2007).